THC is broadly misunderstood, with quite a few now believing that only CBD would be the “professional medical” Section of the cannabis plant. But analysis on cannabis is difficult in the U.S. as a result of strict laws. Mainly because it's even now a Schedule I drug, researche

In 2024, the U.S. Drug Enforcement Administration (DEA) indicated which they intend to reclassify cannabis as being a Program III drug. This rescheduling will acknowledge that cannabis has legitimate clinical functions and might help open up the doorway to exploration on other potential treatmen